Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study)

Introduction: Small intestinal bacterial overgrowth (SIBO) leads to non-specific abdominal discomfort and nutrient malabsorption. Currently, rifaximin is widely applied in SIBO based on its antibacterial and non-absorbable nature. Berberine is a natural component of many popular medicine plants that...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Huaizhu, Lu, Siqi, Zhang, Jindong, Chen, Chen, Du, Yanlin, Wang, Kun, Duan, Liping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974661/
https://www.ncbi.nlm.nih.gov/pubmed/36873985
http://dx.doi.org/10.3389/fphar.2023.1121435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974661/
https://www.ncbi.nlm.nih.gov/pubmed/36873985
http://dx.doi.org/10.3389/fphar.2023.1121435

Ejemplares similares